|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,268 GBX | +0.16% |
|
+3.59% | +6.30% |
| 03:38pm | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
| 10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
AstraZeneca Plc said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.
AstraZeneca on Saturday published a document https://bit.ly/2FNcqu7 describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times.
(Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry)
| 1st Jan change | Capi. | |
|---|---|---|
| +6.30% | 215B | |
| +27.46% | 659B | |
| +27.68% | 557B | |
| -4.24% | 359B | |
| +16.66% | 322B | |
| +9.85% | 297B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.79% | 149B | |
| -5.08% | 146B |
ASTRAZENECA PLC 
